Edgen Stock·Oct 07 2025, 19:47戻る
戻る
Lexeo Therapeutics Shares Advance on FDA Accelerated Approval Pathway Progress for LX2006
Edgen Stock·Oct 07 2025, 19:47
[1] Lexeo: Maintaining Buy Rating Based On FDA Accelerated Approval Feedback (https://seekingalpha.com/article/4828374-lexe ...)[2] Lexeo's gene therapy for Friedreich ataxia shows promising results By Investing.com (https://vertexaisearch.cloud.google.com/groun ...)[3] Lexeo Therapeutics (LXEO) Aims for Accelerated Approval with LX2006 - GuruFocus (https://www.gurufocus.com/news/2025/10/07/lex ...)